Intraocular lymphoma: A series of 14 patients with clinicopathological features and treatment outcomes

Eye

Volumn 17, Issue 4, 2003, Pages 513-521

  Hoffman, Phil M ^a   McKelvie, P ^b   Hall, A J ^a   Stawell, R J ^a   Santamaria, J D ^b  

^a ROYAL VICTORIAN EYE AND EAR HOSPITAL   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

Intraocular lymphoma; Intravitreal methotrexate; Primary central nervous system non Hodgkin's lymphoma (PCNSL); Radiation retinopathy; Radiotherapy; T cell lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; ARABINOSIDE; CISPLATIN; CYCLOPHOSPHAMIDE; CYTOSINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; B CELL LYMPHOMA; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CATARACT; CENTRAL NERVOUS SYSTEM; CLINICAL FEATURE; DRY EYE; EYE DISEASE; FEMALE; HUMAN; INTRAOCULAR LYMPHOMA; KAPLAN MEIER METHOD; KERATOPATHY; MALE; NONHODGKIN LYMPHOMA; OPTIC NERVE ATROPHY; PATHOLOGY; RETINOPATHY; RETROSPECTIVE STUDY; REVIEW; T CELL LYMPHOMA; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 0038621485     PISSN: 0950222X     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.eye.6700378     Document Type: Review

References (46)

1. Cooper EL, Riker JL. Malignant lymphoma of the uveal tract. Am J Ophthalmol 1951; 34: 1153-1158.
2. Fine HA, Mayer RJ. Primary central nervous system lymphoma. Ann Intern Med 1993; 119: 1093-1104.
3. Miller DC, Hochberg FH, Harris NL, Gruber ML, Louis DN, Cohen H. Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989. Cancer 1994; 74: 1383-1397.
4. Eby NL, Grufferman S, Flannelly CM, Schold SC Jr, Vogel FS, Burger PC. Increasing incidence of primary brain lymphoma in the US. Cancer 1988; 62: 2461-2465.
5. Corn BW, Marcus SM, Topham A, Hauck W, Curran WJ Jr. Will primary central nervous system lymphoma be the most frequent brain tumour diagnosed in the year 2000? Cancer 1997; 79: 2409-2413.
6. Freilich RJ, Delattre JY, Monjour A, DeAngelis LM. Chemotherapy without radiation therapy as initial treatment for primary CNS lymphoma in older patients. Neurology 1996; 46: 435-439.
7. Sandor V, Stark-Vancs V, Pearson D, Nussenblat R, Whitcup SM, Brouwers P et al. Phase II trial of chemotherapy alone for primary CNS and intraocular lymphoma. J Clin Oncol 1998; 16: 3000-3006.
8. Kaplan EL, Meier P. Non-parametric evaluation from incomplete observation. J Am Stat Assoc 1958; 53: 457-481.
9. Cox DR. Regression models and life tables. J R Stat Soc 1972; 34: 187-220.
10. Freeman LN, Schachat AP, Knox DL, Michels RG, Green WR. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 1987; 94: 1631-1638.
11. Whitcup SM, de Smet MD, Rubin BI, Palestine AG, Martin DF, Burnier M Jr et al. Intraocular lymphoma. Clinical and histopathological diagnosis. Ophthalmology 1993; 100: 1399-1406.
12. Peterson K, Gordon KB, Heinemann MH, DeAngelis LM. The clinical spectrum of ocular lymphoma. Cancer 1993; 72: 843-849.
13. Cassoux N, Merle-Beral H, Leblond V, Bodaghi B, Miléa D, Gerber S et al. Ocular and central nervous system lymphoma: clinical features and diagnosis. Ocul Immunol Inflamm 2000; 8; 243-250.
14. Char DH, Ljung BM, Miller T, Phillips T. Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology 1988; 95: 625-630.
15. Hunyor AP, Harper A, O'Day J, McKelvie PA. Ocular-central nervous system lymphoma mimicking posterior scleritis with exudative retinal detachment. Ophthalmology 2000; 107: 1955-1959.
16. Kleihues P, Cavenee WK (eds). Malignant lymphomas. In: WHO Classification of Tumours. Pathology and Genetics of Tumours of the Nervous System. IARC Press: Lyon, 2000; pp. 198-203.
17. Brown SM, Jampol LM, Cantrill HL. Intraocular lymphoma presenting as retinal vasculitis. Surv Ophthalmol 1994; 39: 133-140.
18. Char DH, Ljung BM, Deschênes J, Miller TR. Intraocular lymphoma: immunological and cytological analysis. Br J Ophthalmol 1988; 72: 905-911.
19. Goldey SH, Stern GA, Oblon DJ, Mendenhall NP, Smith LJ, Duque RE. Immunophenotypic characterization of an unusual T-cell lymphoma presenting as anterior uveitis. A clinicopathological case report. Arch Ophthalmol 1989; 107: 1349-1353.
20. Davis JL, Viciana AL, Ruiz P. Diagnosis of intraocular lymphoma by flow cytometry. Am J Ophthalmol 1997; 124: 362-372.
21. Ridley ME, McDonald HR, Sternberg Jr P, Blumenkranz MS, Zarbin MA, Schachat AP. Retinal manifestations of ocular lymphoma (reticulum cell sarcoma). Ophthalmology 1992; 99: 1153-1160.
22. Saga T, Ohno S, Matsuda H, Ogasawara M, Kikuchi K. Ocular involvement by a peripheral T-cell lymphoma. Arch Ophthalmol 1984; 102: 399-402.
23. Kohno T, Uchida H, Inomata H, Fukushima S, Takeshita M, Kikuchi M. Ocular manifestations of adult T-cell leukaemia/lymphoma. A clinicopathologic study Ophthalmology 1993; 100: 1794-1799.
24. Williams GC, Holz E, Lee AG, Font RL. T-cell lymphoproliferative disorder of vitreous associated with mycosis fungoides. Arch Ophthalmol 2000; 118: 278-280.
25. Lois N, Hiscott PS, Nash J, Wong D. Immunophenotypic shift in a case of mycosis fungoides with vitreous invasion. Arch Ophthalmol 2000; 118: 1692-1694.
26. Yahalom C, Cohen Y, Averbukh E, Anteby I, Amir G, Pe'er J. Bilateral iridociliary T-cell lymphoma. Arch Ophthalmol 2002; 120: 204-207.
27. Goeminne JC, Brouillard A, Jaumain P, Ferrant A, Snyers B, De Potter P. Bilateral granulomatous panuveitis as initial presentation of diffuse systemic T-cell lymphoma. Ophthalmologica 1999; 213: 323-326.
28. Jensen OA, Kiss K, Johansen S. Intraocular T-cell lymphoma mimicking a ring melanoma. First manifestation of systemic disease. Graefes Arch Clin Exp Ophthalmol 1994; 232: 148-152.
29. Foerster HC. Mycosis fungoides with intraocular involvement. Trans Am Acad Ophthalmol Otol 1960; 64: 308-313.
30. Gärtner J. Mycosis fungoides mit Beteiligung der Aderhaut. Klin Monatsblat Augenheilkd 1989; 131: 61-69.
31. Keltner JL, Fritsch E, Cykiert RC, Albert DM. Mycosis fungoides. Intraocular and central nervous system involvement. Arch Ophthalmol 1977; 95: 645-650.
32. Wolter JR, Leenhouts TM, Hendrix RC. Corneal involvement in mycosis fungoides. Am J Ophthalmol 1963; 55: 315-322.
33. Reim H, Dieler R, Wessing A. Non-Hodgkin-Lymphom mit dem Erscheinungsbild einer Chorioretinitis. Fortschr Ophthalmol 1990; 87: 557-559.
34. Erny BC, Egbert PR, Peat IM, Shorrock K, Rosenthal AR. Intraocular involvement with subretinal pigment epithelium infiltrates by mycosis fungoides. Br J Ophthalmol 1991; 75: 698-701.
35. Leitch RJ, Rennie IG, Parsons MA. Ocular involvement in mycosis fungoides. Br J Ophthalmol 1993; 77: 126-127.
36. Bednar MM, Salerni A, Flanagan ME, Pendlebury WW. Primary central nervous system T-cell lymphoma. J Neurosurg 1991; 74: 668-672.
37. Grant JW, Isaacson PG. Primary central nervous system lymphoma. Brain Pathology 1992; 2: 97-109.
38. McCue MP, Sandrock AW, Lee JM, Harris NL, Hedley-Whyte ET. Primary T-cell lymphoma of the brainstem. Neurology 1993; 43: 377-381.
39. Rothova A, Ooijman F, Kerkhoff F et al. Uveitis masquerade syndromes. Ophthalmology 2001; 108: 386-399.
40. DeAngelis LM. Current management of primary central nervous system lymphoma. Oncology 1995; 9: 63-78.
41. Merchant A, Foster CS. Primary intraocular lymphoma. Int Ophthalmol Clin 1997; 37: 101-115.
42. Parsons JT, Bova FJ, Mendenhall WM, Million RR, Fitzgerald CR. Response of the normal eye to high dose radiotherapy. Oncology 1996; 10: 837-847.
43. Fishburne BC, Wilson DJ, Rosenbaum JT, Neuwelt EA. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 1997; 115: 1152-1156.
44. de Smet MD, Vancs VS, Kohler D, Solomon D, Chan CC. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol 1999; 83:448-551.
45. de Smet MD. Management of non-Hodgkin's lymphoma with intravitreal methotrexate. Bull Soc Belge Ophthalmol 2001; 279: 91-95.
46. Smith JR, Rosenbaum JT, Wilson DJ, Doolittle ND, Siegal T, Neuwelt EA et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology. 2002; 109: 1709-1716.